A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned?

Should consumers be concerned? Consumer genetic testing company 23andMe announced on Wednesday that GlaxoSmithKline purchased a $300 million stake in the company, allowing the pharmaceutical giant to use 23andMe’s trove of genetic data to develop new drugs — and raising new privacy concerns for consumers.
Read more: http://time.com/5349896/23andme-glaxo-smith-kline/?source=Snapzu